Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, P R China.
Endoscopy. 2013;45(3):161-6. doi: 10.1055/s-0032-1326203. Epub 2013 Feb 6.
Recurrence/persistence of symptoms occurs in approximately 20 % of patients after Heller myotomy for achalasia. Controversy exists regarding the therapy for patients in whom Heller myotomy has failed. The aim of the current study was to evaluate the efficacy and feasibility of peroral endoscopic myotomy (POEM), a new endoscopic myotomy technique, for patients with failed Heller myotomy.
A total of 12 patients with recurrence/persistence of symptoms after Heller myotomy, as diagnosed by established methods and an Eckardt score of ≥ 4, were prospectively included. The primary outcome was symptom relief during follow-up, defined as an Eckardt score of ≤ 3. Secondary outcomes were procedure-related adverse events, lower esophageal sphincter (LES) pressure on manometry, reflux symptoms, and medication use before and after POEM.
All 12 patients underwent successful POEM after a mean of 11.9 years (range 2 - 38 years) from the time of the primary Heller myotomy. No serious complications related to POEM were encountered. During a mean follow-up period of 10.4 months (range 5 - 14 months), treatment success was achieved in 11/12 patients (91.7 %; mean score pre- vs. post-treatment 9.2 vs. 1.3; P < 0.001). Mean LES pressure was 29.4 mmHg pre-treatment and 13.5 mmHg post-treatment (P < 0.001). One patient developed mild reflux symptoms and required intermittent medication with proton pump inhibitors.
POEM seems to be a promising new treatment for failed Heller myotomy resulting in short-term symptom relief in > 90 % of cases. Previous Heller myotomy may make subsequent endoscopic remyotomy more challenging, but does not prevent successful POEM.
Heller 肌切开术治疗贲门失弛缓症后,约 20%的患者会出现症状复发/持续存在。对于 Heller 肌切开术失败的患者,治疗方法存在争议。本研究旨在评估经口内镜肌切开术(POEM)这一新的内镜肌切开技术治疗 Heller 肌切开术失败患者的疗效和可行性。
共纳入 12 例因 Heller 肌切开术复发/持续存在症状(根据既定方法和 Eckardt 评分≥4 诊断)的患者。主要结局是随访期间的症状缓解,定义为 Eckardt 评分≤3。次要结局是与手术相关的不良事件、测压时食管下括约肌(LES)压力、反流症状以及 POEM 前后的药物使用情况。
12 例患者在初次 Heller 肌切开术后平均 11.9 年(范围 2-38 年)后成功接受 POEM。无与 POEM 相关的严重并发症。在平均 10.4 个月(范围 5-14 个月)的随访期间,11/12 例患者(91.7%)治疗成功(平均术前评分 9.2 分,术后评分 1.3 分;P<0.001)。术前 LES 压力为 29.4mmHg,术后为 13.5mmHg(P<0.001)。1 例患者出现轻度反流症状,需要间歇性使用质子泵抑制剂。
POEM 似乎是治疗 Heller 肌切开术失败的一种有前途的新方法,90%以上的患者在短期内症状缓解。先前的 Heller 肌切开术可能使随后的内镜再切开更具挑战性,但不会阻止 POEM 的成功。